Galapagos NV risk profile

31 Normal where most of the sector sits

Measured 1 September 2026 from GXE's filed statements. Recomputed nightly.

31 (Normal), driven by Cash conversion at 100, over 3 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation51ElevatedStableDrawdown from the 52-week high — 22.7%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion100AcuteStableCapital spending against operating cash — -0.05x
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position8ContainedStableOperating-margin gap against peers — +23.6 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Galapagos NV